Panacea Biotec388.45
+12.30 (+3.27%)

Panacea Biotec Share Price

388.45+12.30 (+3.27%)
-9.12% past 1 Year

Corporate filings & documents

Announcements

Please note that reminder letters dated 15.09.2026 is being sent to the shareholders holding shares in physical mode requesting them to furnish PAN and KYC details for updation to the Company / RTA along with request to dematerialize the shares with Depository Participant. A copy of the reminder letter is enclosed herewith.
1 week ago
Please note that reminder letters dated 15.09.2026 is being sent to the shareholders holding shares in physical mode requesting them to furnish PAN and KYC details for updation to the Company / RTA along with request to dematerialize the shares with Depository Participant. A copy of the reminder letter is enclosed herewith.
1 week ago
Please find enclosed copies of newspaper advertisement regarding Notice of 42nd AGM Cut-off date and Remote e-Voting information published on September 08 2026.
2 weeks ago
Please find enclosed copies of newspaper advertisement regarding Notice of 42nd AGM Cut-off date and Remote e-Voting information published on September 08 2026.
2 weeks ago
Please find attached intimation regarding Book Closure for the purpose of Annual General Meeting.
2 weeks ago
Please find attached intimation regarding Book Closure for the purpose of Annual General Meeting.
2 weeks ago
Please find attached intimation of letter being sent to shareholders for providing web-link for accessing Annual Report and AGM Notice for FY 2025-26
2 weeks ago
Please find attached intimation of letter being sent to shareholders for providing web-link for accessing Annual Report and AGM Notice for FY 2025-26
2 weeks ago
Please find attached Business Responsibility and Sustainability Report for FY 2025-26
2 weeks ago
Please find attached Business Responsibility and Sustainability Report for FY 2025-26
2 weeks ago
Please find attached Annual Report for FY 2025-26
2 weeks ago
Please find attached Annual Report for FY 2025-26
2 weeks ago
Please find attached Annual Report for Financial Year 2025-26 including Notice of AGM
2 weeks ago
Please find attached Annual Report for Financial Year 2025-26 including Notice of AGM
2 weeks ago
Please find attached details of shares dematerialised during August 2026. A copy of the certificate obtained from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on August 31 2026. is also enclosed herewith.
2 weeks ago
Please find attached details of shares dematerialised during August 2026. A copy of the certificate obtained from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on August 31 2026. is also enclosed herewith.
2 weeks ago
Please find enclosed newspaper copies of the public notice requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of the Company.
1 month ago
Please find enclosed newspaper copies of the public notice requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of the Company.
1 month ago
Please find attached of the extract of statement of Unaudited Financial Results for the quarter ended 30.06.2026 published on 14.08.2026.
1 month ago
Please find attached of the extract of statement of Unaudited Financial Results for the quarter ended 30.06.2026 published on 14.08.2026.
1 month ago
Please find attached Unaudited Financial Results for quarter ended June 30 2026.
1 month ago
Please find attached Unaudited Financial Results for quarter ended June 30 2026.
1 month ago
Please find attached Outcome of Board Meeting held on August 13 2026.
1 month ago
Please find attached Outcome of Board Meeting held on August 13 2026.
1 month ago
Please find attached newspaper copies regarding notice intimating the investors about the opening of Special Window for transfer and dematerialisation of physical shares.
1 month ago
Please find attached newspaper copies regarding notice intimating the investors about the opening of Special Window for transfer and dematerialisation of physical shares.
1 month ago
Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30 2026.The trading window of the Company shall remain closed for all Designated Persons (including their Immediate Relatives) of the Company from July 01 2026 till August 15 2026.
1 month ago
Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30 2026.The trading window of the Company shall remain closed for all Designated Persons (including their Immediate Relatives) of the Company from July 01 2026 till August 15 2026.
1 month ago
Please find attached details of shares dematerialised during July 2026.
1 month ago
Please find attached details of shares dematerialised during July 2026.
1 month ago
We are delighted to inform you that the Company has received Letter of Award for supply of bivalent Oral Polio Vaccine (bOPV) to UNICEF in 10 and 20 dose presentation worth ~US$8.205 million (~Rs.78.24 Crore) in Calendar Year 2028.
1 month ago
We are delighted to inform you that the Company has received Letter of Award for supply of bivalent Oral Polio Vaccine (bOPV) to UNICEF in 10 and 20 dose presentation worth ~US$8.205 million (~Rs.78.24 Crore) in Calendar Year 2028.
1 month ago
The Companys wholly owned subsidiary Panacea Biotec Pharma Ltd. has received a Show Cause Notice (SCN) dated July 23 2026 from the office of the Assistant Commissioner Goods and Services Tax Delhi under Section 73 of Delhi Goods & Services Tax / Central Goods & Services Tax Act & Rules 2017 alleging total tax liability of Rs.4.06 Crore including interest tax and penalty on account of alleged excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23.The requisite disclosure is attached herewith.
2 months ago
The Companys wholly owned subsidiary Panacea Biotec Pharma Ltd. has received a Show Cause Notice (SCN) dated July 23 2026 from the office of the Assistant Commissioner Goods and Services Tax Delhi under Section 73 of Delhi Goods & Services Tax / Central Goods & Services Tax Act & Rules 2017 alleging total tax liability of Rs.4.06 Crore including interest tax and penalty on account of alleged excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23.The requisite disclosure is attached herewith.
2 months ago
We would like to inform you that the Company has on July 16 2026 filed appeal before the Honble High Court of Punjab and Haryana Chandigarh against the remaining 4th award. The requisite disclosure is attached herewith.
2 months ago
We would like to inform you that the Company has on July 16 2026 filed appeal before the Honble High Court of Punjab and Haryana Chandigarh against the remaining 4th award. The requisite disclosure is attached herewith.
2 months ago
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain HUF
2 months ago
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Jain HUF
2 months ago
Please find attached disclosure which is self explanatory
2 months ago
Please find attached disclosure which is self explanatory
2 months ago
Please find attached certificate dated July 01 2026 issued by Skyline Financial Services Pvt. Ltd. RTA under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months ago
Please find attached certificate dated July 01 2026 issued by Skyline Financial Services Pvt. Ltd. RTA under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
2 months ago
We would like to inform that no share has been dematerialised during June 2026. A copy of the certificate obtained from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on June 30 2026 is enclosed herewith.
2 months ago
We would like to inform that no share has been dematerialised during June 2026. A copy of the certificate obtained from the Companys RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on June 30 2026 is enclosed herewith.
2 months ago
We would like to inform you that the trading window of the Company shall remain closed from July 01 2026 till completion of 48 hours from the announcement of the Unaudited financial results for the quarter ending June 30 2026 to the Stock Exchanges.
2 months ago
We would like to inform you that the trading window of the Company shall remain closed from July 01 2026 till completion of 48 hours from the announcement of the Unaudited financial results for the quarter ending June 30 2026 to the Stock Exchanges.
2 months ago
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dr Rajesh Jain
3 months ago
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dr Rajesh Jain
3 months ago
Please find attached newspaper copies regarding notice intimating the investors about the opening of a special window for transfer and dematerialisation of physical shares.
3 months ago
Please find attached newspaper copies regarding notice intimating the investors about the opening of a special window for transfer and dematerialisation of physical shares.
3 months ago

Concalls & investor presentations

Jun 2021

Panacea Biotec Ltd Share Price Today

The Panacea Biotec Ltd share price today is ₹381.35. During the trading session, the Panacea Biotec Ltd share price opened at ₹378.55 and recorded an intraday high of ₹383.00 and a low of ₹376.80. Last closing price was ₹381.25. Over the past 52 weeks, the Panacea Biotec Ltd share price has ranged between ₹292.40 and ₹647.00. The current Panacea Biotec Ltd stock price reflects real-time market activity based on executed trades on the exchange.